We envision a world where advances in vaccines and medicines help all people live longer, healthier lives.
We are your partner for studies in sub-Saharan Africa.
Take advantage of our years of experience conducting studies in countries throughout sub-Saharan Africa. Our localized team has the experience and skills to support your portfolio strategy, determine feasibility, rapidly develop sites and provide end-to-end study support.
Because of our global expertise, responsive approaches and proven solutions, we are two steps ahead, ready to deploy immediately in markets worldwide and able to measure study launch in days rather than weeks.
Reach new markets and access the right patient populations.
Benefit from our unique combination of in-country technical, regulatory and cultural knowledge and an established global presence in Africa, Asia, Europe, Latin America and North America.
By connecting your research strategy with the overarching policy and local communities, we help facilitate communication and engagement efforts for more successful study execution.
As your study needs or the local situation change, we can adapt our processes and workflow. No matter how large or small the project, we remain agile and exact, because your research demands it.
We also invest in our intellectual capital and are experts at rapid start-up and management of complex clinical research at sites diverse in geographic area and research capacity.
Our work complements that of FHI 360, which is grounded in research and science, reinforced by partnerships and focused on strengthening the capacity of individuals, local organizations and national governments.
Together, we can ensure that countries are prepared to respond to threats to
their population’s health.
May 2, 2022
FHI Clinical Inc. announces today it will consult on the go-to-market strategy for COVID-19 related anti-inflammatory therapeutics for Gb Sciences. FHI Clinical will additionally write the draft clinical trial protocol for a first-in-human trial of these proprietary cannabinoid-containing formulations.
Missed the webinar? View the recording to hear about Africa’s strong clinical research foundation, based on collaborative approaches with numerous stakeholders, complex studies with long-term follow-up and a community-centered approach to fostering enrollment and retention.
Several FHI Clinical team members attended the 6th Annual Global Forum on TB Vaccines. Based on their conversations and session attendance, they provide their thoughts on the future of tuberculosis prevention and vaccine development.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA